Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD

Clinical trial NCT06431256 · TERMINATED

Trial details

NCT number: NCT06431256
Sponsor: Ironshore Pharmaceuticals and Development, Inc
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2024-09-13
Primary completion: 2025-07-11
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.